Aviva share price climbs as gilt yields hit a two-month high — what to watch before March results
29 January 2026
1 min read

Aviva share price climbs as gilt yields hit a two-month high — what to watch before March results

London, Jan 29, 2026, 09:43 GMT — Regular session

Aviva shares edged up around 0.5% to 637.8 pence in early London trading on Thursday, while the FTSE 100 climbed roughly 0.6%. Legal & General held steady, and Phoenix Group gained about 0.1%, according to Google Finance data.

Rates are the key factor here. UK life insurers typically track gilts — British government bonds — since yield changes affect both investment returns and capital buffers. Ten-year gilt yields reached their highest level since Nov. 20, hitting 4.569% at 0831 GMT. Futures markets show only limited rate cuts expected this year, with a quarter-point reduction not fully priced in until July.

Inflation data is getting a tweak in the UK. Starting February, the Office for National Statistics will use supermarket checkout “scanner” data. Tests indicate this shift could reduce the average CPI by about 0.03 percentage points over several years. “The price charged at the till, not the price shown on the shelf, will feed into our inflation statistics,” said ONS Deputy Director Mike Hardie. Reuters

Overnight, the Federal Reserve kept the fed funds rate steady between 3.5% and 3.75%, flagging inflation as still “somewhat elevated.” The hold sent bond markets up. “The Fed did nothing and did it with conviction,” Karl Schamotta, chief market strategist at Corpay, told Reuters. Reuters

There was some company-level chatter, though nothing directly tied to Aviva’s balance sheet. Aviva Investors revealed its latest Private Markets Study, showing average allocations to private markets climbed to 12.5% of portfolios. The survey covered 500 institutional investors managing $6.5 trillion in assets. David Hedalen, head of private markets research at Aviva Investors, noted that “for many investors, private markets offer an attractive illiquidity premium” alongside diversification. Aviva Investors

Aviva plc’s next major milestone is its earnings release. The insurer will unveil full-year results on March 5 at 0700 GMT, with an analyst and investor presentation scheduled for later that morning, per its financial calendar.

Investors are zeroing in on how much of the rate shift translates into cash generation and the implications for capital returns. The solvency ratio — a regulator-mandated gauge of capital health — remains crucial, as it directly affects dividend and buyback potential for UK insurers.

Aviva announced earlier that the UK’s Prudential Regulation Authority has greenlit a tweak to Direct Line’s Solvency II capital model (the framework insurers use to calculate capital requirements). The insurer said it expects “a further update” with its full-year results. It also confirmed it remains “on track” to achieve over £0.5 billion in total capital synergies by around the end of 2026. Investegate

The risk is clear-cut. Should gilt yields drop sharply or rate-cut expectations accelerate beyond what investors anticipate, the sector could lose backing fast. For Aviva, any slip in capital assumptions or missteps in hitting integration and synergy goals would probably surface first in the solvency figures.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Labcorp (LH) Rises 3.4% as Investors Look to Earnings Growth
    July 24, 2026, 9:11 AM EDT. Shares of Labcorp Holdings (LH) climbed 3.4% to finish at $291.02, fueled by heavy trading volumes and bullish sentiment ahead of the Q2 2026 results set for release on July 30. Analysts predict a 5.4% increase in revenue year-over-year to $3.72 billion, while per-share earnings are expected to reach $4.79, a 10.1% gain. The stock is rated a Zacks Rank #2 (Buy), as upward earnings estimate revisions point to possible further advances.
Commonwealth Bank of Australia share price drops as inflation revives RBA hike bets — what to watch next
Previous Story

Commonwealth Bank of Australia share price drops as inflation revives RBA hike bets — what to watch next

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work
Next Story

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work